BPH - Benign Prostatic Enlargement
Effectiveness of medical and surgical therapies for lower urinary tract symptoms in the community setting - Abstract
September 20, 2012
Does prostate configuration affect the efficacy and safety of GreenLight HPS™ laser photoselective vaporization prostatectomy (PVP)? - Abstract
September 18, 2012
Finasteride reduces the risk of incident clinical benign prostatic hyperplasia - Abstract
September 17, 2012
Chronic urinary retention in men: How we define it, and how does it affect treatment outcome - Abstract
September 14, 2012
Combination pharmacological therapies for the management of benign prostatic hyperplasia - Abstract
September 13, 2012
Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: A comparison to overall Medicare inflation - Abstract
September 12, 2012
Transurethral intraprostatic Botulinum toxin-A injection: A novel treatment for BPH refractory to current medical therapy in poor surgical candidates - Abstract
September 6, 2012
Effects of interview mode on assessments of erectile and ejaculatory dysfunction among men with benign prostatic hyperplasia (BPH) - Abstract
September 4, 2012
Evaluation of tadalafil effect on lower urinary tract symptoms of benign prostatic hyperplasia in patients treated with standard medication - Abstract
September 4, 2012
Relationship of sex hormones and nocturia in lower urinary tract symptoms induced by benign prostatic hyperplasia - Abstract
September 3, 2012
Dutasteride/tamsulosin fixed-dose combination for the treatment of benign prostatic enlargement - Abstract
August 31, 2012
Serial changes in sexual function following holmium laser enucleation of the prostate: A short-term follow-up study - Abstract
August 30, 2012
Rapid ambulatory pathway laser prostatectomy is safe: Results within the global period - Abstract
August 28, 2012
Outcome analysis of the urethral stent Memotherm® - Abstract
August 27, 2012